<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Cytokinetics | Company News & Executive Profiles - CYTK | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/cytokinetics.html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Cytokinetics]]></description>
	<s:counts start="0" returned="10" found="13" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Cytokinetics' Market Potential]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F172910-cytokinetics-market-potential%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[In the news: Cytokinetics CYTK has initiated phase I clinical trial to investigate the pharmacokinetic profile of CK-2017357. Cytokinetics has also initiated the second part, or "Part B", of a previously initiated, Phase I clinical trial of CK-2017357 in healthy male volunteers.     CK-2017357 is a small...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 12 Nov 2009 12:23:35 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/prohost+biotech.html"><![CDATA[Prohost Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://resources.bnet.com/topic/cytokinetics+inc..html"><![CDATA[Cytokinetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="tickers">CYTK,CYTK</category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics, Inc. Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-293940.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Your first question comes from Mark Monane of Needham & Company. Glenn Hanus - Needham & Company Hi. This is Glenn answering for Mark. My first question is on the recently initiated Phase IIa trial for multiple dosing for intermediate and oral for the PK....]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 30 Apr 2009 17:37:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/needham+%2526+co..html"><![CDATA[Needham & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/trial.html"><![CDATA[Trial]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="tickers">CYTK</category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-267685.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Your first question comes from Mark Monane with Needham. Your line is open. Mark Monane &#8211; Needham Hi, thank you. Good afternoon. And thank you for the reviewing 2008 and look into 2009 in this fine afternoon in New York City. Robert Blum Good afternoon,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 10 Feb 2009 18:22:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/muscle.html"><![CDATA[Muscle]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/needham.html"><![CDATA[Needham]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="tickers">CYTK</category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics Announces Interim Clinical Trial Data Relating to CK-1827452 Presented at the European Society of Cardiology Congress 2008]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200809/ai_n28053736]]></link>
		<description><![CDATA[Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that additional interim results from an ongoing Phase IIa clinical trial of CK-1827452 were presented as a poster presentation at the European Society of Cardiology ESC Congress 2008, at the Messe München GmbH in Munich, Germany.  The trial is evaluating an intravenous formulation...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 02 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cohort.html"><![CDATA[cohort]]></category>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://resources.bnet.com/topic/formulation.html"><![CDATA[formulation]]></category>
		<category domain="http://resources.bnet.com/topic/gsk.html"><![CDATA[GSK]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="tickers">CYTK</category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to Be Presented at the European Society of Cardiology Congress 2008]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200808/ai_n28035247]]></link>
		<description><![CDATA[Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that additional interim results from an ongoing Phase IIa clinical trial of CK-1827452 are scheduled to be presented as a poster presentation at the European Society of Cardiology ESC Congress 2008, to be held August 30-September 3, 2008 at the Messe München GmbH in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 25 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://resources.bnet.com/topic/gsk.html"><![CDATA[GSK]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="tickers">CYTK</category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics Inc., Business Update Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-228819.html]]></link>
		<description><![CDATA[ Earnings Call ExcerptCytokinetics Inc. CYTK Business Update Call  March 31, 2008 8:00 am ET Executives Dr. John R. Teerlink - Associate Professor of Medicine Dr. Andrew A. Wolff - Senior Vice President of Clinical Research and Development and Chief Medical Officer Dr. John Cleland - Professor of Cardiology...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 31 Mar 2008 11:17:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="tickers">CYTK</category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics Q3 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-232266.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Your first question comes from Michael Aberman with Credit Suisse. Robert Blum Hey, Michael. Michael Aberman - Credit Suisse I guess the first the comment that you expect is about this Phase IIa data in 2008, some of us were expecting it earlier 2008. Can...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 31 Oct 2007 17:05:29 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="tickers">CYTK</category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics Announces Clinical Trials Data to Be Presented at the 2007 Annual Meeting of the American Society of Clinical Oncology]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200705/ai_n19161823]]></link>
		<description><![CDATA[Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that three abstracts summarizing data from clinical trials relating to its oncology program will be presented at the 2007 Annual Meeting of the American Society of Clinical Oncology ASCO in Chicago, IL, June 1-5, 2007.  Two of these abstracts relate to clinical trials...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 18 May 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://resources.bnet.com/topic/gsk.html"><![CDATA[GSK]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="tickers">CYTK</category>
	</item>
	<item>
		<title><![CDATA[Nabi Biopharmaceuticals provides update on bacterial infections programs and Cytokinetics files $100 million shelf.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200506/ai_n19988324]]></link>
		<description><![CDATA[M2 PRESSWIRE-15 June 2005-US Financial Network: Nabi  Biopharmaceuticals provides update on bacterial infections programs and  Cytokinetics files $100 million shelfC1994-2005 M2 COMMUNICATIONS LTD    RDATE:16062005    City of Industry, CA - Biotechnology industry news provide by  Financial News USA (OTC: FNWU). Nabi Biopharmaceuticals...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 15 Jun 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://resources.bnet.com/topic/infection.html"><![CDATA[infection]]></category>
		<category domain="http://resources.bnet.com/topic/nabi+biopharmaceuticals.html"><![CDATA[Nabi Biopharmaceuticals]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NABI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYTK,NABI,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics to present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference, Dynavax to webcast presentation at Pacific Growth Equities 2005 Life Sciences Conference.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200505/ai_n19976423]]></link>
		<description><![CDATA[M2 PRESSWIRE-26 May 2005-US Financial Network: Cytokinetics to  present at the Friedman Billings Ramsey 9th Annual Growth Investor  Conference, Dynavax to webcast presentation at Pacific Growth Equities  2005 Life Sciences ConferenceC1994-2005 M2 COMMUNICATIONS LTD    RDATE:26052005    City of Industry, CA - Biotechnology...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 26 May 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/friedman+billings+ramsey.html"><![CDATA[Friedman Billings Ramsey]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FBR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYTK,FBR,NDAQ</category>
	</item>
</channel>
</rss>
